How I treat mixed-phenotype acute leukemia von Wolach, Ofir, Stone, Richard M.

Volltext

Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial von Shanafelt, Tait D, Wang, Xin Victoria, Hanson, Curtis A, Paietta, Elisabeth M, O'Brien, Susan, Barrientos, Jacqueline, Jelinek, Diane F, Braggio, Esteban, Leis, Jose F, Zhang, Cong Christine, Coutre, Steven E, Barr, Paul M, Cashen, Amanda F, Mato, Anthony R, Singh, Avina K, Mullane, Michael P, Little, Richard F, Erba, Harry, Stone, Richard M, Litzow, Mark, Tallman, Martin, Kay, Neil E

Volltext

Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML von Vo, Thanh-Trang, Ryan, Jeremy, Carrasco, Ruben, Neuberg, Donna, Rossi, Derrick J., Stone, Richard M., DeAngelo, Daniel J., Frattini, Mark G., Letai, Anthony

Volltext

BETing on rational combination therapy in mutant FLT3 acute myeloid leukemia von Stone, Richard M

Volltext

Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy von Wolach, Ofir, Stone, Richard M

Volltext

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients von Bejar, Rafael, Lord, Allegra, Stevenson, Kristen, Bar-Natan, Michal, Pérez-Ladaga, Albert, Zaneveld, Jacques, Wang, Hui, Caughey, Bennett, Stojanov, Petar, Getz, Gad, Garcia-Manero, Guillermo, Kantarjian, Hagop, Chen, Rui, Stone, Richard M., Neuberg, Donna, Steensma, David P., Ebert, Benjamin L.

Volltext

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations von Lindsley, R. Coleman, Mar, Brenton G., Mazzola, Emanuele, Grauman, Peter V., Shareef, Sarah, Allen, Steven L., Pigneux, Arnaud, Wetzler, Meir, Stuart, Robert K., Erba, Harry P., Damon, Lloyd E., Powell, Bayard L., Lindeman, Neal, Steensma, David P., Wadleigh, Martha, DeAngelo, Daniel J., Neuberg, Donna, Stone, Richard M., Ebert, Benjamin L.

Volltext

Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms von Van Egeren, Debra, Escabi, Javier, Nguyen, Maximilian, Liu, Shichen, Reilly, Christopher R., Patel, Sachin, Kamaz, Baransel, Kalyva, Maria, DeAngelo, Daniel J., Galinsky, Ilene, Wadleigh, Martha, Winer, Eric S., Luskin, Marlise R., Stone, Richard M., Garcia, Jacqueline S., Hobbs, Gabriela S., Camargo, Fernando D., Michor, Franziska, Mullally, Ann, Cortes-Ciriano, Isidro, Hormoz, Sahand

Volltext

MEN1 mutations mediate clinical resistance to menin inhibition von Perner, Florian, Stein, Eytan M., Wenge, Daniela V., Singh, Sukrit, Kim, Jeonghyeon, Apazidis, Athina, Rahnamoun, Homa, Anand, Disha, Marinaccio, Christian, Hatton, Charlie, Wen, Yanhe, Stone, Richard M., Schaller, David, Mowla, Shoron, Xiao, Wenbin, Gamlen, Holly A., Stonestrom, Aaron J., Persaud, Sonali, Ener, Elizabeth, Cutler, Jevon A., Doench, John G., McGeehan, Gerard M., Volkamer, Andrea, Chodera, John D., Nowak, Radosław P., Fischer, Eric S., Levine, Ross L., Armstrong, Scott A., Cai, Sheng F.

Volltext

TET2-mutant clonal hematopoiesis and risk of gout von Agrawal, Mridul, Niroula, Abhishek, Cunin, Pierre, McConkey, Marie, Shkolnik, Veronica, Kim, Peter G., Wong, Waihay J., Weeks, Lachelle D., Lin, Amy E., Miller, Peter G., Gibson, Christopher J., Sekar, Aswin, Schaefer, Inga-Marie, Neuberg, Donna, Stone, Richard M., Bick, Alexander G., Uddin, Md Mesbah, Griffin, Gabriel K., Jaiswal, Siddhartha, Natarajan, Pradeep, Nigrovic, Peter A., Rao, Deepak A., Ebert, Benjamin L.

Volltext

Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches von Winer, Eric S., Stone, Richard M.

Volltext

FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity von Mysore, Vijayashree, Cullere, Xavier, Mears, Joseph, Rosetti, Florencia, Okubo, Koshu, Liew, Pei X., Zhang, Fan, Madera-Salcedo, Iris, Rosenbauer, Frank, Stone, Richard M., Aster, Jon C., von Andrian, Ulrich H., Lichtman, Andrew H., Raychaudhuri, Soumya, Mayadas, Tanya N.

Volltext

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management von Shimony, Shai, Stahl, Maximilian, Stone, Richard M.

Volltext

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia von MROZEK, Krzysztof, MARCUCCI, Guido, PETTENATI, Mark J, HEEREMA, Nyla A, BLOCK, Annemarie W, PATIL, Shivanand R, BAER, Maria R, KOLITZ, Jonathan E, MOORE, Joseph O, CARROLL, Andrew J, STONE, Richard M, LARSON, Richard A, NICOLET, Deedra, BLOOMFIELD, Clara D, MAHARRY, Kati S, BECKER, Heiko, WHITMAN, Susan P, METZELER, Klaus H, SCHWIND, Sebastian, WU, Yue-Zhong, KOHLSCHMIDT, Jessica

Volltext

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark von Taylor, Justin, Haddadin, Michael, Upadhyay, Vivek A., Grussie, Erwin, Mehta-Shah, Neha, Brunner, Andrew M., Louissaint, Abner, Lovitch, Scott B., Dogan, Ahmet, Fathi, Amir T., Stone, Richard M., Tallman, Martin S., Rampal, Raajit K., Neuberg, Donna S., Stevenson, Kristen E., Horwitz, Steven M., Lane, Andrew A.

Volltext

Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis von PARDANANI, Animesh, GOTLIB, Jason R, JAMIESON, Catriona, CORTES, Jorge E, TALPAZ, Moshe, STONE, Richard M, SILVERMAN, Michael H, GILLILAND, D. Gary, SHORR, Jolene, TEFFERI, Ayalew

Volltext

Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies von DuMontier, Clark, Uno, Hajime, Hshieh, Tammy, Zhou, Guohai, Chen, Richard, Magnavita, Emily S, Mozessohn, Lee, Javedan, Houman, Stone, Richard M, Soiffer, Robert J, Driver, Jane A, Abel, Gregory A

Volltext

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax von Montero, Joan, Stephansky, Jason, Cai, Tianyu, Griffin, Gabriel K, Cabal-Hierro, Lucia, Togami, Katsuhiro, Hogdal, Leah J, Galinsky, Ilene, Morgan, Elizabeth A, Aster, Jon C, Davids, Matthew S, LeBoeuf, Nicole R, Stone, Richard M, Konopleva, Marina, Pemmaraju, Naveen, Letai, Anthony, Lane, Andrew A

Volltext

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis von Stone, Richard M., Manley, Paul W., Larson, Richard A., Capdeville, Renaud

Volltext

Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-R... von FISCHER, Thomas, STONE, Richard M, KLIMEK, Virginia M, NIMER, Stephen D, GILLILAND, D. Gary, DUTREIX, Catherine, HUNTSMAN-LABED, Alice, VIRKUS, Jodi, GILES, Francis J, DEANGELO, Daniel J, GALINSKY, Ilene, ESTEY, Elihu, LANZA, Carlo, FOX, Edward, EHNINGER, Gerhard, FELDMAN, Eric J, SCHILLER, Gary J

Volltext